332 related articles for article (PubMed ID: 11253121)
1. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
[TBL] [Abstract][Full Text] [Related]
2. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
[TBL] [Abstract][Full Text] [Related]
3. Brenner tumor of the ovary: a comparative immunohistochemical and ultrastructural study with transitional cell carcinoma of the bladder.
Ordóñez NG; Mackay B
Ultrastruct Pathol; 2000; 24(3):157-67. PubMed ID: 10914427
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of uroplakins, urothelial specific proteins, in ovarian Brenner tumors, normal tissues, and benign and neoplastic lesions of the female genital tract.
Ogawa K; Johansson SL; Cohen SM
Am J Pathol; 1999 Oct; 155(4):1047-50. PubMed ID: 10514386
[TBL] [Abstract][Full Text] [Related]
5. Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis.
Soslow RA; Rouse RV; Hendrickson MR; Silva EG; Longacre TA
Int J Gynecol Pathol; 1996 Jul; 15(3):257-65. PubMed ID: 8811388
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathologic features observation of ovarian transitional cell tumors].
Wang L; Dong Y; Li Q; Li H; Sun X; Zhou X; Li X
Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):118-22. PubMed ID: 25916643
[TBL] [Abstract][Full Text] [Related]
7. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
Cuatrecasas M; Catasus L; Palacios J; Prat J
Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
[TBL] [Abstract][Full Text] [Related]
8. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas.
Kaufmann O; Volmerig J; Dietel M
Am J Clin Pathol; 2000 May; 113(5):683-7. PubMed ID: 10800401
[TBL] [Abstract][Full Text] [Related]
9. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
Oliva E; Amin MB; Jimenez R; Young RH
Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
[TBL] [Abstract][Full Text] [Related]
10. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.
Esheba GE; Longacre TA; Atkins KA; Higgins JP
Am J Surg Pathol; 2009 Mar; 33(3):347-53. PubMed ID: 19092634
[TBL] [Abstract][Full Text] [Related]
11. Ovarian transitional cell carcinoma represents a poorly differentiated form of high-grade serous or endometrioid adenocarcinoma.
Takeuchi T; Ohishi Y; Imamura H; Aman M; Shida K; Kobayashi H; Kato K; Oda Y
Am J Surg Pathol; 2013 Jul; 37(7):1091-9. PubMed ID: 23681072
[TBL] [Abstract][Full Text] [Related]
12. Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors.
Seidman JD; Khedmati F
Arch Pathol Lab Med; 2008 Nov; 132(11):1753-60. PubMed ID: 18976011
[TBL] [Abstract][Full Text] [Related]
13. [Benign and malignant Brenner tumor of the ovary: a clinicopathological and immunohistochemical study].
Peng ZN
Zhonghua Bing Li Xue Za Zhi; 1992 Dec; 21(6):333-5. PubMed ID: 1284387
[TBL] [Abstract][Full Text] [Related]
14. Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor.
Ali RH; Seidman JD; Luk M; Kalloger S; Gilks CB
Int J Gynecol Pathol; 2012 Nov; 31(6):499-506. PubMed ID: 23018212
[TBL] [Abstract][Full Text] [Related]
15. Ovarian Brenner tumors and Walthard nests: a histologic and immunohistochemical study.
Roma AA; Masand RP
Hum Pathol; 2014 Dec; 45(12):2417-22. PubMed ID: 25281026
[TBL] [Abstract][Full Text] [Related]
16. p63 expression in ovarian tumours: a marker for Brenner tumours but not transitional cell carcinomas.
Liao XY; Xue WC; Shen DH; Ngan HY; Siu MK; Cheung AN
Histopathology; 2007 Oct; 51(4):477-83. PubMed ID: 17880529
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.
Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC
Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713
[TBL] [Abstract][Full Text] [Related]
18. Selective expression of cytokeratin polypeptides in various epithelia of human Brenner tumor.
Lifschitz-Mercer B; Czernobilsky B; Shezen E; Dgani R; Leitner O; Geiger B
Hum Pathol; 1988 Jun; 19(6):640-50. PubMed ID: 2454213
[TBL] [Abstract][Full Text] [Related]
19. Ovarian Brenner tumors. II. Malignant.
Roth LM; Czernobilsky B
Cancer; 1985 Aug; 56(3):592-601. PubMed ID: 4005816
[TBL] [Abstract][Full Text] [Related]
20. Transitional cell carcinomas of the ovary and bladder are immunophenotypically different.
Ordóñez NG
Histopathology; 2000 May; 36(5):433-8. PubMed ID: 10792484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]